Table 8.

Laboratory parameters of the study population.

	AG		ACG		RG		RCG
IGF-1, ng/mL, mean (±SD), n	297.55 † †	117	244.63	32	158.30	102	166.97	38
	(±104.30)		(±111.82)		(±56.88)		(±58.96)
Glucose, mg/dL, mean (±SD), n	82.70 †	117	84.41	32	87.06	102	86.79	38
	(±9.78)		(±12.29)		(±10.31)		(±20.13)
HOMA Index, mean (±SD), n	4.00	107	5.26	32	2.93 †	101	2.64	38
	(±6.40)		(±9.80)		(±2.68)		(±5.09)
HbA1c, mmol/mol, mean (±SD), n	33.38 †	117	33.03	32	34.87	102	34.47	38
	(±3.40)		(±3.17)		(±4.69)		(±5.00)
Fructosamine, µmol/L, mean (±SD), n	265.72	117	266.28	32	267.13	102	272.26	38
	(±21.44)		(±21.59)		(±20.63)		(±23.65)
Cholesterol, mg/dL, mean (±SD), n	167.26 †	117	177.75	32	231.74	102	197.13	38
	(±30.99)		(±38.37)		(±22.77)		(±36.93)
LDL, mg/dL, mean (±SD), n	92.93 †	116	100.44	32	126.26	101	115.32	38
	(±26.86)		(±35.48)		(±38.15)		(±34.62)
TG, mg/dL, mean (±SD), n	91.01 † †	117	128.94	32	129.93 †	102	86.45	38
	(±51.72)		(±118.71)		(±79.32)		(±40.01)
CRP, mg/dL, mean (±SD), n	0.19	117	0.24	32	0.26	102	0.24	38
	(±0.22)		(±0.35)		(±0.19)		(±0.24)
Leukocytes, G/L, mean (±SD), n	7.27	117	6.78	32	6.68 †	102	5.72	38
	(±1.78)		(±1.76)		(±1.80)		(±1.78)
Vitamin D, ng/mL, mean (±SD), n	22.71	117	25.05	32	27.24	102	23.92	38
	(±12.12)		(±23.41)		(±23.88)		(±10.83)
Zinc, µg/dL, mean (±SD), n	82.91	115	83.26	31	85.11 * #	102	90.68	38
	(±16.53)		(±12.08)		(±17.12)		(±14.81)

(AG = acne group, ACG = acne control group, RG = rosacea group, RCG = rosacea control group. CRP = C-reactive protein, dL = deciliter, G = giga, HOMA-Index = Homeostasis Model Assessment = (Insulin × Glucose)/405, IGF-1= insulin-like growth factor 1, LDL = low-density lipoprotein-cholesterol, L = liter, mg = milligram, ng = nanogram, n = number, SD = standard deviation, TG = triglycerides). * = p < 0.05 AG vs. ACG, RG vs. RCG; ^# = p < 0.05 AG vs. RG; ^† = p < 0.01 AG vs. ACG, RG vs. RCG;^†= p < 0.01 AG vs. RG.